Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has entered into an agreement to develop a companion diagnostic (CDx) test for dalcetrapib, a therapeutic from DalCor Pharmaceuticals (DalCor), which will target patients with a specific genotype who have experienced a recent Acute Coronary Syndrome (ACS) event.
Canada2001 Boulevard Robert Bourassa,
Suite 1700
Montreal, Quebec H3A 2A6
Tel.: +1 514-508-5099
Fax.: +1 514-564-6424
Email: [email protected]
SWITZERLANDBaarerstrasse 2 CH-6302 Zug
Tel.: +41 41 727 67 89
Email: [email protected]
UNITED KINGDOMQ3, the Square Randalls Way
Leatherhead KT22 7TW
Tel: +44 207-842-2275
Email: [email protected]
UNITED STATES677 N. Washington Blvd., Suite 132 Sarasota, Florida 34236
Tel: +1 941-306-2362
Email: [email protected]